Blood Typing

to transfuse women and newborns with blood loss or severe anemia

Diagnostic
Diagnostic
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Blood Typing
    Representative Product

    Condition
    Low levels of hemoglobin can result from acute or chronic blood loss, excessive red cell breakdown or failure to produce sufficient levels of red cells resulting in anemia. Anemia occurs in 42% of global pregnancies as the mother's body is unable to produce red blood cells in proportion to the 50% increase in blood volume associated with pregnancy. Acute blood loss most often occurs postpartum due to uterine relaxation. Low concentrations of red blood cells makes it difficult for the body to oxygenate itself and the fetus. 

     

    Blood transfusion is often used to correct this, however, the transfused blood cells must be compatible with the recipients blood. Incmopatible blood results in a dangerous immune response to the foreign transfusion. If incompatible blood is transfused, the patient may suffer from hemolysis, renal failure and possibly death.

    Mechanism of Action

    Blood group tests use the principle of agglutination to differentiate between blood types. To trigger agglutination, whole blood samples are mixed with three test reagents: antibodies matching the A, B, and Rh surface antigens. Samples with antibody-antigen pairs clump together. This visible agglutination signals the presence of the antigen in the blood. Agglutination can be performed on an open surface, test tube, or micro-array for high throughput. 

    Current use in High-Resource Settings
    Blood typing is typically done in a centralized laboratory setting wherein high throughput instruments such as the Immucor Galileo which can load 224 samples at a time for blood type as well as limited infectious disease screening. Blood banks can typically run 30,000 samples a year with one such machine.

    Application in Low-Resource Settings
    Blood banking does not adequately cover the population requiring transfusion in many low-resource settings, and patients requiring a transfusion will sometimes ask compatible donors from their friends and family to accompany them for direct donation. These donors may submit to rapid, card-based confirmatory testing immediately (like the Eldoncard above) before transfusion. Determining blood type, however, is only a first step. Especially in areas with high prevalence of HIV, infectious disease screening is an important part of transfusion safety.

    REPRESENTATIVE DEVICES

    MAKE
    MODEL
    PRICE*
    TECH
    STATUS
    NOTES

    Immunotec

    Galileo
    $50,000
    Automated
    Marketed
    Commonly used in blood banks

    Generic

    Various
    $1
    Wet reagent
    Marketed
    Requires considerable training

    Eldon Biological

    Eldoncard
    $6
    Dry reagent
    Marketed
    Simplest technology for use

    * Prices are approximated. Actual pricing can, and will vary by marketplace and market conditions.

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    POTENTIAL OPPORTUNITIES FOR IMPROVEMENT

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Physician, Skilled Birth Attendant
    Hours
    5 minutes

    To have an impact, ideally a non-skilled health worker could read and interpret the card.

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None
    Biohazard
    Sterile wipe, lancet, and clean water
    None

    Dry antibodies sealed in foil envelopes are fairly robust, but required clean water for reconstitution.

    COST

    Device Cost (Approx)
    Cost/course (Approx)
    $1-$10
    $1-$10

    Cost reductions are likely possible for this name brand product

    OTHER

    Portability
    Regulatory
    Efficacy
    <100g
    Approved by FDA Bureau of Medical Devices, Class II, section 510(K) for physical exams, blood type screening in clinics and employment settings

    Additional devices required for impact: Diagnosis of anemia or blood loss, compatible blood type for transfusion, infectious disease screening capability for donor blood, donor and recipient side transfusion equipment

Sources: Gooch A, Parker J, Wray J, Qureshi H. Guideline for blood grouping and antibody testing in pregnancy. London (UK): British Committee for Standards in Haematology (BCSH); 2006. Kenya National Blood Transfusion Service January 2010 Newsletter.